Literature DB >> 29286487

Using the Dot Assay to Analyze Migration of Cell Sheets.

Christina H Stuelten1.   

Abstract

Although complex organisms appear static, their tissues are under a continuous turnover. As cells age, die, and are replaced by new cells, cells move within tissues in a tightly orchestrated manner. During tumor development, this equilibrium is disturbed, and tumor cells leave the epithelium of origin to invade the local microenvironment, to travel to distant sites, and to ultimately form metastatic tumors at distant sites. The dot assay is a simple, two-dimensional unconstrained migration assay, to assess the net movement of cell sheets into a cell-free area, and to analyze parameters of cell migration using time-lapse imaging. Here, the dot assay is demonstrated using a human invasive, lung colony forming breast cancer cell line, MCF10CA1a, to analyze the cells' migratory response to epidermal growth factor (EGF), which is known to increase malignant potential of breast cancer cells and to alter the migratory phenotype of cells.

Entities:  

Mesh:

Year:  2017        PMID: 29286487      PMCID: PMC5755524          DOI: 10.3791/56451

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  17 in total

1.  In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro.

Authors:  Chun-Chi Liang; Ann Y Park; Jun-Lin Guan
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 2.  Epidermal growth factor receptor (EGFR) signaling in cancer.

Authors:  Nicola Normanno; Antonella De Luca; Caterina Bianco; Luigi Strizzi; Mario Mancino; Monica R Maiello; Adele Carotenuto; Gianfranco De Feo; Francesco Caponigro; David S Salomon
Journal:  Gene       Date:  2005-12-27       Impact factor: 3.688

3.  Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.

Authors:  S J Santner; P J Dawson; L Tait; H D Soule; J Eliason; A N Mohamed; S R Wolman; G H Heppner; F R Miller
Journal:  Breast Cancer Res Treat       Date:  2001-01       Impact factor: 4.872

Review 4.  A review of the influence of growth factors and cytokines in in vitro human keratinocyte migration.

Authors:  Philip V Peplow; Marissa P Chatterjee
Journal:  Cytokine       Date:  2013-03-11       Impact factor: 3.861

5.  Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer.

Authors:  Christina H Stuelten; Johanna I Busch; Binwu Tang; Kathleen C Flanders; Akira Oshima; Emily Sutton; Tatiana S Karpova; Anita B Roberts; Lalage M Wakefield; John E Niederhuber
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

6.  Quantifying stretching and rearrangement in epithelial sheet migration.

Authors:  Rachel M Lee; Douglas H Kelley; Kerstin N Nordstrom; Nicholas T Ouellette; Wolfgang Losert
Journal:  New J Phys       Date:  2013-02-25       Impact factor: 3.729

7.  Collective migration of an epithelial monolayer in response to a model wound.

Authors:  M Poujade; E Grasland-Mongrain; A Hertzog; J Jouanneau; P Chavrier; B Ladoux; A Buguin; P Silberzan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-28       Impact factor: 11.205

8.  TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

Authors:  Binwu Tang; Mary Vu; Timberly Booker; Steven J Santner; Fred R Miller; Miriam R Anver; Lalage M Wakefield
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.

Authors:  Michael C Weiger; Vidya Vedham; Christina H Stuelten; Karen Shou; Mark Herrera; Misako Sato; Wolfgang Losert; Carole A Parent
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.